Table 3.
Effect of NCE treatment on cerebral MDA and GSH levels.Values are shown as the mean ± SD of 7 mice in each group. Tukey’s Post hoc test was used to compare between groups.
| Groups | GSH (mg/gr protein) | MDA (μg/mg protein) |
|---|---|---|
| Control | 0.33 ± 0.07 | 0.24 ± 0.03 |
| NCE 150 | 0.31 ± 0.06 | 0.25 ± 0.04 |
| SCZ | 0.13 ± 0.01*** | 0.44 ± 0.07*** |
| ARI | 0.24 ± 0.04*++ | 0.25 ± 0.04+++ |
| KET + NCE 70 | 0.12 ± 0.03*** | 0.33 ± 0.05 *++ |
| KET + NCE 150 | 0.26 ± 0.01+++ | 0.23 ± 0.02+++ |
SCZ; schizophrenia, ARI; aripiprazole, NCE (Nostoc commune extract) 70 and 150 mg/kg *P < 0.05, ***P < 0.001 as compared to the control group; ++ P<0.01, +++ P<0.001 as compared to SCZ group.